However, current clinical evidence does not show semaglutide triggers or worsens Graves' disease in patients whose thyroid condition is already controlled
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
New delivery routes including sublingual, intranasal, and inhaled formulations have attracted patent interest [9, 33, 34] and some scientific attention [35], though market signals remain limited
Xiang RH, Wang JQ, Li ZG (2024) Crosstalk of methylglyoxal and calcium signaling in maize ( Zea mays L.) thermotolerance through methylglyoxal-scavenging system
, ,
Molecular Psychiatry 18, 961962.CrossRefGoogle ScholarPubMed Hall, MH, Chen, CY, Cohen, BM, Spencer, KM, Levy, DL, ngr, D and Smoller, JW (2015) Genomewide association analyses of electrophysiological endophenotypes for schizophrenia and psychotic bipolar disorders: a preliminary report